Sun, May 19, 2013, 11:21 AM EDT - U.S. Markets closed
Company selling shares to fund it through Afrezza's approval.
Company's billionaire C.E.O. converts debt to equity at $2.59/share.
Great entry point.
300% return within 12 months or sooner.
Partnership could happen ay any time.
300% upside over the next 12 months.
Sooner if a big pharma partnership is announced.